279 related articles for article (PubMed ID: 10868465)
1. Atypical antipsychotics and weight gain--a systematic review.
Taylor DM; McAskill R
Acta Psychiatr Scand; 2000 Jun; 101(6):416-32. PubMed ID: 10868465
[TBL] [Abstract][Full Text] [Related]
2. Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.
Rummel-Kluge C; Komossa K; Schwarz S; Hunger H; Schmid F; Lobos CA; Kissling W; Davis JM; Leucht S
Schizophr Res; 2010 Nov; 123(2-3):225-33. PubMed ID: 20692814
[TBL] [Abstract][Full Text] [Related]
3. Risperidone versus other atypical antipsychotics for schizophrenia.
Komossa K; Rummel-Kluge C; Schwarz S; Schmid F; Hunger H; Kissling W; Leucht S
Cochrane Database Syst Rev; 2011 Jan; (1):CD006626. PubMed ID: 21249678
[TBL] [Abstract][Full Text] [Related]
4. Quetiapine versus other atypical antipsychotics for schizophrenia.
Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
[TBL] [Abstract][Full Text] [Related]
5. [Atypical neuroleptics: new approaches to drug therapy of schizophrenic disorders].
Hilger E; Kasper S
Wien Klin Wochenschr; 2000 Dec; 112(24):1031-8. PubMed ID: 11204312
[TBL] [Abstract][Full Text] [Related]
6. Amisulpride versus other atypical antipsychotics for schizophrenia.
Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Silveira da Mota Neto JI; Kissling W; Leucht S
Cochrane Database Syst Rev; 2010 Jan; (1):CD006624. PubMed ID: 20091599
[TBL] [Abstract][Full Text] [Related]
7. Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.
Atmaca M; Kuloglu M; Tezcan E; Ustundag B
J Clin Psychiatry; 2003 May; 64(5):598-604. PubMed ID: 12755665
[TBL] [Abstract][Full Text] [Related]
8. Six-month review of weight and metabolic parameters in patients receiving clozapine, risperidone, olanzapine, or quetiapine.
Kelly DL; Kreyenbuhl J; Love RC; Van-Duong Q; Conley RR
J Clin Psychiatry; 2003 Sep; 64(9):1133-4. PubMed ID: 14628994
[No Abstract] [Full Text] [Related]
9. Review of atypical antipsychotics and weight gain.
Sussman N
J Clin Psychiatry; 2001; 62 Suppl 23():5-12. PubMed ID: 11603886
[TBL] [Abstract][Full Text] [Related]
10. Comparing the side effect profile of the atypical antipsychotics.
Alao AO; Malhotra K; Dewan MJ
West Afr J Med; 2002; 21(4):313-5. PubMed ID: 12665274
[TBL] [Abstract][Full Text] [Related]
11. [Psychotropics and weight gain].
Sahli Ch; Bryois Ch
Praxis (Bern 1994); 2004 Aug; 93(35):1393-401. PubMed ID: 15468580
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials.
Leucht S; Pitschel-Walz G; Abraham D; Kissling W
Schizophr Res; 1999 Jan; 35(1):51-68. PubMed ID: 9988841
[TBL] [Abstract][Full Text] [Related]
13. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
14. A typical mood stabilizers: a "typical role for atypical antipsychotics.
Malhi GS; Berk M; Bourin M; Ivanovski B; Dodd S; Lagopoulos J; Mitchell PB
Acta Psychiatr Scand Suppl; 2005; (426):29-38. PubMed ID: 16104066
[TBL] [Abstract][Full Text] [Related]
15. Novel antipsychotics: comparison of weight gain liabilities.
Wirshing DA; Wirshing WC; Kysar L; Berisford MA; Goldstein D; Pashdag J; Mintz J; Marder SR
J Clin Psychiatry; 1999 Jun; 60(6):358-63. PubMed ID: 10401912
[TBL] [Abstract][Full Text] [Related]
16. Second-generation antipsychotic medications and risk of pneumonia in schizophrenia.
Kuo CJ; Yang SY; Liao YT; Chen WJ; Lee WC; Shau WY; Chang YT; Tsai SY; Chen CC
Schizophr Bull; 2013 May; 39(3):648-57. PubMed ID: 22282455
[TBL] [Abstract][Full Text] [Related]
17. Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis.
Geddes J; Freemantle N; Harrison P; Bebbington P
BMJ; 2000 Dec; 321(7273):1371-6. PubMed ID: 11099280
[TBL] [Abstract][Full Text] [Related]
18. The value of atypical antipsychotics in the treatment of schizophrenia.
Jessen LM
Manag Care; 2002 Jul; 11(7 Suppl):8-12; discussion 12-3. PubMed ID: 12181875
[No Abstract] [Full Text] [Related]
19. Differences in the effect of second-generation antipsychotics on prolactinaemia: six weeks open-label trial in female in-patients.
Svestka J; Synek O; Tomanová J; Rodáková I; Cejpková A
Neuro Endocrinol Lett; 2007 Dec; 28(6):881-8. PubMed ID: 18063941
[TBL] [Abstract][Full Text] [Related]
20. [Atypical antipsychotics].
Naber D
Nervenarzt; 2000 May; 71(5):327-8. PubMed ID: 10846707
[No Abstract] [Full Text] [Related]
[Next] [New Search]